Adaptimmune Therapeutics plc total revenue, net income and dynamics of changes in US dollar today
Adaptimmune Therapeutics plc current income and income for the latest reporting periods. The dynamics of net revenue of Adaptimmune Therapeutics plc decreased. The change amounted to -1 068 000 $. The dynamics of net revenue is shown in comparison with the previous report. The dynamics of Adaptimmune Therapeutics plc net income fell by -1 150 000 $. The assessment of the dynamics of Adaptimmune Therapeutics plc net income was made in comparison with the previous report. Adaptimmune Therapeutics plc online financial report chart. The value of "net income" Adaptimmune Therapeutics plc on the graph is displayed in blue. The value of Adaptimmune Therapeutics plc assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Dates of Adaptimmune Therapeutics plc finance reports: 30/06/2017, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of Adaptimmune Therapeutics plc is available online for such a date - 31/03/2021. Gross profit Adaptimmune Therapeutics plc is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Adaptimmune Therapeutics plc is -24 072 000 $
Cost of revenue Adaptimmune Therapeutics plc is the total cost of producing and distributing of products and services of a company. Cost of revenue Adaptimmune Therapeutics plc is 24 506 000 $ Total revenue Adaptimmune Therapeutics plc refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Adaptimmune Therapeutics plc is 434 000 $ Operating income Adaptimmune Therapeutics plc is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Adaptimmune Therapeutics plc is -37 889 000 $
Net income Adaptimmune Therapeutics plc is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Adaptimmune Therapeutics plc is -37 763 000 $ Current assets Adaptimmune Therapeutics plc is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Adaptimmune Therapeutics plc is 359 293 000 $ Total assets Adaptimmune Therapeutics plc refers to the total amount of assets owned by a person or entity. Total assets Adaptimmune Therapeutics plc is 411 581 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-24 072 000 $
-24 275 000 $
-22 874 000 $
-19 958 000 $
-29 380 000 $
-25 354 000 $
-22 019 000 $
-21 290 000 $
17 308 000 $
9 038 000 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
24 506 000 $
25 777 000 $
24 067 000 $
20 460 000 $
29 617 000 $
25 511 000 $
22 019 000 $
22 769 000 $
23 484 000 $
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
434 000 $
1 502 000 $
1 193 000 $
502 000 $
237 000 $
157 000 $
-
1 479 000 $
40 792 000 $
9 038 000 $
8 196 000 $
4 270 000 $
27 185 000 $
3 521 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
237 000 $
157 000 $
-
1 479 000 $
40 792 000 $
9 038 000 $
8 196 000 $
4 270 000 $
27 185 000 $
3 521 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-37 889 000 $
-37 513 000 $
-35 875 000 $
-30 253 000 $
-40 121 000 $
-35 502 000 $
-33 792 000 $
-32 106 000 $
7 018 000 $
-28 877 000 $
-28 740 000 $
-29 700 000 $
-4 960 000 $
-23 780 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-37 763 000 $
-36 613 000 $
-35 432 000 $
-29 880 000 $
-39 302 000 $
-41 087 000 $
-27 412 000 $
-36 173 000 $
5 242 000 $
-43 845 000 $
-21 078 000 $
-27 263 000 $
-878 000 $
-20 215 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
-
26 624 000 $
25 732 000 $
25 148 000 $
24 034 000 $
19 591 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
38 323 000 $
39 015 000 $
37 068 000 $
30 755 000 $
40 358 000 $
35 659 000 $
33 792 000 $
33 585 000 $
33 774 000 $
37 915 000 $
36 936 000 $
33 970 000 $
32 145 000 $
27 301 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
359 293 000 $
398 152 000 $
426 733 000 $
458 087 000 $
146 970 000 $
175 133 000 $
200 301 000 $
231 095 000 $
261 605 000 $
161 654 000 $
195 663 000 $
230 183 000 $
253 904 000 $
237 744 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
411 581 000 $
451 142 000 $
479 022 000 $
512 201 000 $
208 251 000 $
239 521 000 $
270 440 000 $
276 736 000 $
309 625 000 $
211 299 000 $
247 068 000 $
281 147 000 $
301 377 000 $
284 279 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
32 432 000 $
56 882 000 $
78 466 000 $
122 359 000 $
39 409 000 $
34 574 000 $
49 917 000 $
68 379 000 $
153 081 000 $
42 312 000 $
57 735 000 $
88 296 000 $
149 558 000 $
126 154 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
37 401 000 $
28 293 000 $
23 435 000 $
24 437 000 $
29 566 000 $
42 310 000 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
161 834 000 $
208 261 000 $
231 858 000 $
202 021 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
60 568 000 $
52 530 000 $
50 785 000 $
29 851 000 $
33 470 000 $
46 197 000 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
29.08 %
21.93 %
18.78 %
10.79 %
10.81 %
21.86 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
309 157 000 $
341 227 000 $
376 206 000 $
407 585 000 $
147 683 000 $
186 991 000 $
219 655 000 $
246 885 000 $
276 155 000 $
165 102 000 $
191 262 000 $
202 984 000 $
228 985 000 $
229 495 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-29 608 000 $
-34 168 000 $
-36 203 000 $
-31 685 000 $
9 939 000 $
-35 363 000 $
-47 279 000 $
-21 356 000 $
13 489 000 $
-18 009 000 $
Last revenue report of Adaptimmune Therapeutics plc was 31/03/2021. According to last financial report total revenue in Adaptimmune Therapeutics plc was 434 000 US dollar and changed by +1.56% since last year. Net income in Adaptimmune Therapeutics plc was -37 763 000 $ in last quartal, net income changes to 0%.
Current cash Adaptimmune Therapeutics plc - the sum of all of the cash a company has on the date of report. Current cash Adaptimmune Therapeutics plc is 32 432 000 $
